473733-02-7

Basic information

• Product Name: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)
• Synonyms: 2-Furanmethanamine, a-ethyl-4-(1-methylethyl)-, (aR)-;(R)-1-(4-isopropylfuran-2-yl)propan-1-amine;a-ethyl-4-(1-Methylethyl)-;2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI);(1R)-1-(4-propan-2-ylfuran-2-yl)propan-1-amine
• CAS NO: 473733-02-7
• Molecular Formula: C₁₀H₁₇NO
• Molecular Weight: 167.25
• Product Categories: ISOPROPYL
• Mol File: 473733-02-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(473733-02-7)
• EPA Substance Registry System: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(473733-02-7)

Safety Data

• Hazardous Substances Data: 473733-02-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Development:
2-Furanmethanamine, alpha-ethyl-4-(1-methylethyl)-, (alphaR)-(9CI) is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it a promising candidate for the development of new drugs with novel therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, 2-Furanmethanamine, alpha-ethyl-4-(1-methylethyl)-, (alphaR)-(9CI) serves as a versatile building block for the creation of complex organic molecules. Its amine functionality allows for a wide range of chemical reactions, enabling the synthesis of diverse organic compounds with potential applications in various industries.
Used in Laboratory Research:
2-Furanmethanamine, alpha-ethyl-4-(1-methylethyl)-, (alphaR)-(9CI) is employed as a research tool in laboratories to study its chemical properties, reactivity, and potential applications. Researchers use 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI) to explore new reaction pathways, develop innovative synthetic methods, and gain insights into the structure-activity relationships of related compounds.

Upstream product

• 101384-09-2 4-(1-Methyl-1-nitro-ethyl)-furan-2-carboxylic acid methyl ester 
• 1874-23-3 methyl 5-nitrofuran-2-carboxylate 
• 59413-65-9 (4-isopropyl-furan-2-yl)-methanol 
• 38071-65-7 4-isopropyl-furan-2-carboxylic acid methyl ester 
• 16015-07-9 4-Isopropyl-2-furaldehyde 
• 946113-01-5 C₁₃H₂₁NO₂ 
• 811-49-4 ethyllithium 

Downstream Products

• 681512-03-8 C₂₁H₂₇N₅O₄S 

Relevant articles and documents

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists

A novel series of cyclobutenedione centered C(4)-alkyl substituted furanyl analogs was developed as potent CXCR2 and CXCR1 antagonists. Compound 16 exhibits potent inhibitory activities against IL-8 binding to the receptors (CXCR2 Ki = 1 nM, IC50 = 1.3 nM; CXCR1 Ki = 3 nM, IC50 = 7.3 nM), and demonstrates potent inhibition against both Gro-α and IL-8 induced hPMN migration (chemotaxis: CXCR2 IC50 = 0.5 nM, CXCR1 IC50 = 37 nM). In addition, 16 has shown good oral pharmacokinetic profiles in rat, mouse, monkey, and dog.

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.